Harry Sugiarto, CFA Managing Director, ICG...Confidential & Trade Secret 3 European senior secured...
Transcript of Harry Sugiarto, CFA Managing Director, ICG...Confidential & Trade Secret 3 European senior secured...
European senior secured loans: A portfolio contextHarry Sugiarto, CFA – Managing Director, ICG
June 2019
Biography
16 years in credit investing
Multi-credit portfolio manager
CFA charterholder
3Confidential & Trade Secret
European senior secured loans: A portfolio context
Comparing European high yield to loans: The value of diversification
Diversification by name
Diversification by sector
The long-term risk & return profile of European senior secured loans
A cross-asset class perspective
Comparing private equity to senior secured loans: First loss vs Last loss
Evaluating risks in European senior secured loans today
Putting cov-lite in perspective
Diversification benefits
European high yield has become a mainstream credit allocation
Europe: Size of European high yield market1
Index value (€ billion)
Note:
1. Source: ICE Bank of America Merrill Lynch. Data to 30 April 2019. Index does not include all issuers in the market. Further detail and definition of the indices are provided in the index disclaimer in the Notes section.
5Confidential & Trade Secret
European loans & high yield: Market development
0
50
100
150
200
250
300
350
Jan-98 Jan-00 Jan-02 Jan-04 Jan-06 Jan-08 Jan-10 Jan-12 Jan-14 Jan-16 Jan-18
European high yield market (ICE BAML HY ex-financials)
European loans are a less common allocation, but similar size
Europe: Size of high yield and loan markets1
Index value (€ billion)
Note:
1. Source: Credit Suisse, Bank of America Merrill Lynch. Data to 30 April 2019. Index does not include all issuers in the market. CS WELLI is the Credit Suisse Western European Leveraged Loan Index. Further detail and
definition of the indices are provided in the index disclaimer in the Notes section.
6Confidential & Trade Secret
European loans & high yield: Market development
0
100
200
300
400
500
600
Jan-98 Jan-00 Jan-02 Jan-04 Jan-06 Jan-08 Jan-10 Jan-12 Jan-14 Jan-16 Jan-18
European loan market (CS WELLI) European high yield market (ICE BAML HY ex-financials)
Low overlap between European loan & HY issuer pools
European loan & high yield indices: Ticker overlap (indices at 30 September 2018)
Note:
1. Source: Credit Suisse, ICE Bank of America Merrill Lynch. Index does not include all issuers in the market. CS WELLI is the Credit Suisse Western European Leveraged Loan Index. Further detail and definition of the
indices are provided in the index disclaimer in the Notes section.
7Confidential & Trade Secret
European loans & high yield: Diversification benefits
35246 310
High yield
only tickers
Loan only
tickers
Common
tickers
Uneven sector distribution between European loans & HY
European loan & high yield indices: Sector distribution (common classification: CS), % index weight
Source: Credit Suisse, ICE Bank of America Merrill Lynch. Data at 30 April 2019. Index does not include all issuers in the market. CS WELLI is the Credit Suisse Western European Leveraged Loan Index. Further detail and
definition of the indices are provided in the index disclaimer in the Notes section.
8Confidential & Trade Secret
European loans & high yield: Diversification benefits
0
10
20
30
40
50
60
70
80
90
100
HY Loans
UTILITY
TRANSPORTATION
SERVICE
RETAIL
METALS/MINERALS
MEDIA/TELECOM
MANUFACTURING
INFORMATION TECHNOLOGY
HOUSING
HEALTHCARE
GAMING/LEISURE
FOREST PROD/CONTAINERS
FOOD/TOBACCO
FOOD AND DRUG
FINANCIAL
ENERGY
CONSUMER NON-DURABLES
CONSUMER DURABLES
CHEMICALS
AEROSPACE
European loan & high yield indices: Sector distribution (common methodology), % index weight
Source: Credit Suisse, ICE Bank of America Merrill Lynch. Data to 30 April 2019. Index does not include all issuers in the market. CS WELLI is the Credit Suisse Western European Leveraged Loan Index. Further detail and
definition of the indices are provided in the index disclaimer in the Notes section.
9Confidential & Trade Secret
European loans & high yield: Diversification benefits
11.9
3.1
0
10
20
30
40
50
60
70
80
90
100
HY Loans
UTILITY
TRANSPORTATION
SERVICE
RETAIL
METALS/MINERALS
MEDIA/TELECOM
MANUFACTURING
INFORMATION TECHNOLOGY
HOUSING
HEALTHCARE
GAMING/LEISURE
FOREST PROD/CONTAINERS
FOOD/TOBACCO
FOOD AND DRUG
FINANCIAL
ENERGY
CONSUMER NON-DURABLES
CONSUMER DURABLES
CHEMICALS
AEROSPACE
Default risks often cluster in a single sector
2018 European high yield index returns by sector
Source: ICE Bank of America Merrill Lynch (HPID).
10Confidential & Trade Secret
European loans & high yield: Diversification benefitsSignificant sector dispersion within 2018 high yield returns
-8%
-7%
-6%
-5%
-4%
-3%
-2%
-1%
0%
1%
2%
Au
tom
otiv
e
Bas
ic In
du
stry
Cap
ital G
oo
ds
Co
ns
um
er G
oo
ds
En
erg
y
Hea
lthc
are
Le
isu
re
Me
dia
Rea
l Es
tate
Reta
il
Se
rvic
es
Te
ch
no
log
y &
Ele
ctro
nic
s
Te
lec
om
mu
nic
atio
ns
Tra
nsp
orta
tion
Utility
Security & seniority value across credit
1. Source: S&P LCD, December 2018.
2. Source: Moody’s Corporate Default & Recovery Rates, February 2018.
11Confidential & Trade Secret
European loans & high yield: Risk mitigation
Global Average Corporate Debt Recovery Rates Measured by Ultimate Recoveries (%)2
0%
20%
40%
60%
80%
100%
Loans Sr. SecuredBonds
Sr. UnsecuredBonds
SubordinatedBonds
1987-2017
Illustrative LBO capital structure 1
Equity 47.80%
First lien 4.8x
Second lien & other debt 0.6x
Long-term risk & return profile
European loans & high yield: Risk & returnA cross-asset perspective: Standalone efficiency
Returns versus volatility across asset classes (5 years, USD Hedged)
Source: European Loans – CS WELLI. European HY - ICE BAML HEAG. EUR Gvmt – Euro 1-10yr index, E5AS. EUR IG – Euro investment grade non-financials index, EN00. US Loans – CS LLI. US HY – ICE BAML HCNF.
US IG – US Investment grade non-financials, CF0X. US Treasuries – 7-10yr index, G0Q0. 3M US Libor – US0003M. Emerging Market Debt – EM Euro Corporate index, EMEB. Stoxx 600 – SXXHUN. S&P 500 – SPXT.
Global Aggregate – Bloomberg Barclays Global Aggregate – LEGATRUH.
See index disclaimer in at the end of the presentation. Data as at 31 May 2019.
13Confidential & Trade Secret
European HY
US HY
European Loans
US Loans
US Treasuries (7-10yrs)
Stoxx 600
S&P 500
Global Agg
EUR IG US IG
EUR Gvmt (1-10yrs)
Emerging Market Debt
3M US Libor
0%
2%
4%
6%
8%
10%
0% 2% 4% 6% 8% 10% 12%
Returns
Standard deviation
European loan index returns more tightly distributed
1. Source: Credit Suisse, ICE Bank of America Merrill Lynch. Data to 30 April 2019. Index does not include all issuers in the market. CS WELLI is the Credit Suisse Western European Leveraged Loan Index. Further detail
and definition of the indices are provided in the index disclaimer in the Notes section.
14Confidential & Trade Secret
European loans & high yield: Risk & return
3
5
13
22
10
5
21
15
38
5
1
0
10
20
30
40
-5,-4 -4,-3 -3,-2 -2,-1 -1,-0 0,+1 +1,+2 +2,+3 +3,+4
HPID (European HY) CS WELLI (European loans)
Distribution of monthly index returns (EUR hedged), May 2014 - April 2019 (60 observations)
Fundamental & technical drivers of return distribution
15Confidential & Trade Secret
European loans & high yield: Risk & return
Fundamental drivers
• Interest rates
• Floating vs fixed
• Default & Recovery outcomes
• Secured vs unsecured
• Sector distribution
• Geography
• Sponsorship
• Private equity vs corporate vs family-owned
Technical drivers
• Investor base & fund flows
• UCITS eligibility
• CLO creation
European loans & high yield: Risk & returnA cross market perspective: provision of yield
Yield versus rating by asset class
BAAA
Source: ICE BAML, Credit Suisse, Bloomberg, S&P ratings, 31 March 2019. Further detail and definition of the indices are provided in the index disclaimer in the Notes section.
16Confidential & Trade Secret
5-year Bund
10-year Bund
5-year BTP (Italy)
5-year Bonos (Spain)
BAML Euro corp IG ABAML Euro corp IG BBB
BAML Euro corp HY BB
CS WELLI loan index
BAML Euro corp HY B
-1%
0%
1%
2%
3%
4%
5%
6%
European loans & Private equity relationshipPE-owned companies dominate European loan issuance
European senior secured loan issuance: Sponsored (Private equity) vs non-sponsored
Notes
1. Further detail and definition of the indices are provided in the index disclaimer in the Notes section.
Source: S&P ratings, 31 March 2019.
17Confidential & Trade Secret
90% 91% 88%84%
80%85% 86% 84% 87% 89%
85% 85%
76%71% 71% 73%
77%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Not Sponsored Sponsored
High overlap between European loan & PE investee pools
Source: ICG
18Confidential & Trade Secret
European loans & Private equity relationship
High yield Loans
Private equity
Strong flows into private equity funds
Private equity dry powder: All buyout funds globally, USDbn
Source: Prequin, December 2018
19Confidential & Trade Secret
European loans & private equity relationship
0
100
200
300
400
500
600
700
800
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Is it consistent to be positive on PE & negative on loans?
20Confidential & Trade Secret
European loans & private equity relationship
Se
nio
r se
cu
red
loa
nE
qu
ity
Se
nio
r se
cu
red
loa
nE
qu
ity
Se
nio
r se
cu
red
loa
nE
qu
ity
Se
nio
r se
cu
red
loa
nE
qu
ity
Se
nio
r se
cu
red
loa
nE
qu
ity
Se
nio
r se
cu
red
loa
nE
qu
ity
Se
nio
r se
cu
red
loa
nE
qu
ity
Se
nio
r se
cu
red
loa
nE
qu
ity
0-50% Enterprise value
Target return 4-6%
“Last loss”
50-100% Enterprise value
Target return 15+%
“First loss”
Source: ICG
Putting cov-lite in perspective
This metric gets a lot of focus today
Cov-lite % of institutional loan issuance in Europe
Source: S&P LCD, December 2018
22Confidential & Trade Secret
Putting cov-lite in perspective
7%0%
9%
21%
36%
51%
62%
76%
87%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2007 2008-2011 2012 2013 2014 2015 2016 2017 2018
Only one of many important metrics in credit
Example risk factors when making a credit call
23Confidential & Trade Secret
Putting cov-lite in perspective
Source: ICG
Loan-to-value significantly lower now than pre-crisis
Equity as a percentage of total sources in European LBOs
Source: S&P LCD, December 2018
24Confidential & Trade Secret
Putting cov-lite in perspective
32.7% 32.9% 32.5%
42.1%
45.4%
46.9%
44.2%
47.7%
42.4%41.2%
41.7%
48.6%
44.2%
47.8%
20%
25%
30%
35%
40%
45%
50%
20
05
20
06
20
07
20
08
20
09
20
10
20
11
20
12
20
13
20
14
20
15
20
16
20
17
20
18
Putting cov-lite in perspectiveWill recovery rates improve or deteriorate versus history?
Comparison of new issue loan metrics: 2007 & 2018
Source: Moody’s, S&P LCD, Prequin. 31 March 2019.* Recovery % is 1987-2017 Moody’s global average
25Confidential & Trade Secret
2007 2018
Cov-lite % 7% 87%
Proforma Leverage (xEBITDA), primary 6.0x 5.4x
Proforma EBITDA / Int. cover, primary 2.5x 4.2x
Equity, % of EV, primary 32.5% 47.8%
Global PE buyout dry powder $438bn $694bn
New issue TLB/C loan spread 265 376
Recovery % 80* ?
Index Disclaimer:
HEAG: Bank of America Merrill Lynch BB-B Euro high yield non-financial fixed & floating rate constrained index. CS WELLI: Credit Suisse western leveraged loan index all denominations. CS LLI: Credit
Suisse US leveraged loan index. S&P ELLI: Standard & Poor’s European leveraged loans index. HEAD: BAML Euro non-financial high yield constrained index. HCNF: BAML US non-financial constrained.
H0EN: BAML US HY energy index. HE20: BAML single-B Euro HY index. EN00: BAML Euro non-financial index (IG corporate). CF0X: BAML US non-financial index (IG corporate). EG04: BAML 7-10 year
Euro government index. G9O2: BAML 10+ year US Treasury index. Barclays Global Agg: Barclays Global Aggregate US investment grade bond index. SPXT: S&P500 total return index. SXXGR: Stoxx 600
gross return index.
The returns for the indices are being provided for comparison purposes only and the comparisons do not mean that there necessarily will be a correlation between the returns of the fund, on the one hand, and
the indices, on the other hand. The indices have not been selected to represent an appropriate benchmark against which to compare the fund’s performance; but, rather, is disclosed to allow for comparison
of the fund’s performance to that of these well-known and widely recognized indices. The returns of the fund may differ from the indices in that, among other reasons, the fund is actively managed and may
use leverage. The indices are not available for direct investment, are unmanaged and are not subject to fees and expenses, including transaction costs, typically associated with the management of loan
accounts. In addition, the fund’s holdings will likely differ significantly from the securities that comprise the indices and the differences may be material. Past results are not necessarily indicative of future
results and no representation is made that results similar to those shown can be achieved.
Benchmarks used in these materials are broad-based indices which are used for comparative purposes only and have been selected as they are well known and easily recognizable by investors.
Comparisons to benchmarks have limitations because benchmarks have volatility and other material characteristics that may differ from this transaction. For example, investments made by the Issuer may
differ significantly in terms of security holdings, industry weightings and asset allocation from those of the benchmark. Accordingly, investment results and the volatility of the strategy in respect of this
transaction may differ from those of the benchmark. Also, the indices noted in this presentation are unmanaged, are not available for direct investment, and are not subject to management fees, transaction
costs or other types of expenses that the Issuer may incur. In addition, the performance of the indices reflects reinvestment of dividends and, where applicable, capital gain distributions. Therefore investors
should carefully consider these limitations and differences when evaluating the comparative benchmark data performance. No party involved in or related to compiling, computing or creating the index data
makes any express or implied warranties or representations with respect to such data (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of
originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of such data.
Notes
26Confidential & Trade Secret
This document is being provided to you by the subsidiaries or affiliates of Intermediate Capital Group Plc (“ICG”, and together with their respective directors, officers,
employees, partners, members, shareholders, advisers and agents, as the context requires, “the ICG Parties”) on a strictly confidential basis and no part may be
reproduced or redistributed in any form, by any means without the prior express written consent of ICG. This document is intended only for information purposes and
convenient reference and does not create any legally binding obligation on any of the ICG Parties. The ICG Parties expressly disclaim any liability for the use, misuse,
or distribution of this information to unauthorised recipients.
This document: (i) is not intended as an offer or solicitation with respect to the purchase or sale of any security or financial instrument; (ii) is not to be relied upon in
evaluating the merits of investing in any securities; and (iii) is provided solely as reference material for background purposes. You should be aware that investing in a
fund sponsored by ICG (an “ICG Fund”) involves a high degree of risk, and there can be no assurance that an ICG Fund’s investment objective will be achieved or
that you will receive a return on your capital. The possibility of partial or total loss of capital from an investment in an ICG Fund will exist and you must be prepared to
bear such losses. You should refrain from investing in an ICG Fund unless you fully understand all the risks involved and you independently determine that the
investment is suitable for you. ICG is not your designated investment advisor.
ICG may encounter potential conflicts of interest in connection with the activities of an ICG Fund. Please see the applicable ICG Fund’s offering memorandum or any
other such similar documents for additional information. A private offering of interests in an ICG Fund may only be made pursuant to the final confidential private
placement memorandum for the fund and any supplements (or any other such similar documents) thereto (the “Memorandum”) and the fund’s governing and
subscription documents (together, the “Offering Documents”), which may be furnished to qualified investors on a confidential basis at their request for their
consideration in connection with such offering. The information contained herein will be superseded by and is qualified in its entirety by reference to the Offering
Documents, which contains additional information about the investment objective, terms and conditions of an investment in the fund and also contains tax information
and risk and conflict of interest disclosures that are important to any investment decision regarding the fund. No person has been authorized to give any information or
make any representations other than as contained in the Memorandum and, if given or made, any such information or representation must not be relied upon as
having been authorized by the fund or any of the ICG Parties. A prospective investor should not invest in any fund interests unless satisfied that it (alone or together
with its investment representative) has asked for and received all information that would enable the investor (or both of them) to evaluate the merits and risks of the
proposed investment.
Although certain information has been obtained from, and is based upon sources that we consider reliable, none of the ICG Parties guarantee its accuracy, and it may
be incomplete or condensed. All opinions, projections and estimates constitute the judgement of the ICG Parties, as of the date of the document and are subject to
change without notice. The ICG Parties make no representation or warranty, express or implied as to the fairness, correctness, accuracy or completeness of this
document. The ICG Parties accept no responsibility for any loss arising for any action taken or not taken by anyone using the information contained herein. This
document is not to be relied upon in substitution for the exercise of independent judgment. ICG may have issued, and may in the future issue, other communications
that are inconsistent with, and reach different conclusions from, the information contained herein. This document reflects the different assumptions, views and
analytical methods of the analysts who prepared them and ICG is under no obligation to ensure that such communications are brought to the attention of any recipient
of this document. Past performance should not be taken as an indication or guarantee regarding future performance, and no representation or warranty, express or
implied is made regarding future performance. Moreover, certain information contained herein constitute “forward-looking statements,” which may be identified by the
use of forward-looking terminology such as “may,” “will”, “should,” “expect,” “anticipate,” “target,” “project,” “forecast,” “estimate,” “intend,” “continue” or “believe,” or the
negatives thereof or other variations thereon or comparable terminology. Any forward-looking statements or results in this presentation are based upon current
assumptions, may be simplified and may depend on events outside ICG’s control. Due to various risks and uncertainties actual events or results or the actual
performance of the fund may differ materially from those reflected or contemplated in such forward-looking statements. Statements herein are made as of the date
hereof unless stated otherwise herein.
Disclaimer
Confidential & Trade Secret27
Intermediate Capital Managers Limited (ICML) is authorised and regulated by the UK Financial Conduct Authority. It is not intended for retail clients and is intended
only for investors whom are “eligible counterparties” or “professional clients” as defined by the FCA, and may not, therefore, be redistributed to other classes of
investors. ICML has filed certain portions of Form ADV with the US Securities and Exchange Commission (SEC) as an exempt reporting adviser and have certain
limited reporting obligations to, and may be subject to examination by, the SEC, but is not registered as an investment adviser under the US Investment Advisers Act
1940. This document is not intended to provide, and should not be relied upon, for accounting, legal, tax advice or investment recommendations. You should consult
your tax, legal, accounting or other advisors about the issues discussed herein. This document is neither investment research nor a research recommendation as
defined by the FCA.
For the avoidance of doubt, this document will not be issued to or directed at, and any investment in an ICG Fund will not be available to, persons in any country
where such actions would be contrary to local laws or regulations in that relevant country. This document is not intended for distribution to, or use by any person or
entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation.
Please note that this presentation is for educational purposes only, for delivery to CFA Society VBA Netherlands
Disclaimer
28Confidential & Trade Secret